Lilly closed the trial on June 10, less than a month after it had started, according to a US registry of clinical trials that was updated late Wednesday. A similar study in obesity patients without diabetes remains active, according to the website.
The experimental shot is a cornerstone of the US drugmaker’s strategy for addressing the muscle loss common in patients who shed weight quickly. Others, including